A Randomized Controlled Study Comparing Linagliptin and Glargine Insulin in Long-Term Care Residents with Type 2 Diabetes

被引：0
|
作者：
Umpierrez, Guillermo E.
Chachkhiani, David
Cardona, Saumeth
Saiyed, Sahebi
Wang, Heqiong
Johnson, Thedore, III
Doan, John
Vellanki, Priyathama
Fayfman, Maya
Haw, Sonya
Pasquel, Francisco J.
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1272-P
引用
收藏
页码：A341 / A341
页数：1
相关论文
共 50 条
  • [31] Evaluation of the long-term efficacy of insulin glargine (LANTUS®) in patients with type 1 diabetes in clinical practice
    Schreiber, S
    Russmann, A
    DIABETES, 2003, 52 : A456 - A456
  • [32] Insulin glargine provides long-term effective glycemic control in children and adolescents with type 1 diabetes
    Dunger, DB
    Edge, JA
    Skvor, J
    DIABETES, 2002, 51 : A426 - A426
  • [33] Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial
    Dashora, U. K.
    Sibal, L.
    Ashwell, S. G.
    Home, P. D.
    DIABETIC MEDICINE, 2007, 24 (04) : 344 - 349
  • [34] Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes -: A randomized, controlled trial
    Fritsche, A
    Schweitzer, MA
    Häring, HU
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (12) : 952 - 959
  • [35] Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial
    de Jager, J.
    Kooy, A.
    Schalkwijk, C.
    van der Kolk, J.
    Lehert, P.
    Bets, D.
    Wulffele, M. G.
    Donker, A. J.
    Stehouwer, C. D. A.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (01) : 59 - 70
  • [36] Long-term β-carotene supplementation and risk of type 2 diabetes mellitus -: A randomized controlled trial
    Liu, SM
    Ajani, U
    Chae, C
    Hennekens, C
    Buring, JE
    Manson, JE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (11): : 1073 - 1075
  • [37] Effects of Long-term Treatment of Linagliptin on Glycemic Control in Japanese Patients with Type 2 Diabetes
    Kusunoki, Masataka
    Natsume, Yukie
    Tsutsui, Hideyo
    Miyata, Tetsuro
    Tsutsumi, Kazuhiko
    Oshida, Yoshiharu
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (08) : 1153 - 1159
  • [38] Cost-effectiveness of exenatide versus insulin glargine for the treatinent of type 2 diabetes in a UK setting: a long-term health economic study
    Ray, J. A.
    Secnik, K.
    Yurgin, N.
    Valentine, W. J.
    Roze, S.
    McKendrick, J.
    Foos, V.
    Palmer, A. J.
    DIABETOLOGIA, 2006, 49 : 477 - 477
  • [39] Effectiveness and long-term safety of linagliptin in patients with type 2 diabetes and severe renal impairment
    Patel, S.
    Weber, S.
    Emser, A.
    von Eynatten, M.
    Woerle, H. -J.
    Gibelin, B.
    Katsadze, V.
    DIABETES & METABOLISM, 2012, 38 : A103 - A103
  • [40] Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment
    Newman, J.
    McGill, J. B.
    Patel, S.
    Friedrich, C.
    Sauce, C.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S333 - S333
12345